Healthy Ageing: OpportunityPharma Companies – Asrar Qureshi’s Blog Post #1335
Pakistan’s pharmaceutical industry should evolve beyond treating illness toward prevention, early diagnosis, chronic disease management, digital healthcare, nutrition, healthy ageing, and research. By forming cross-sector partnerships, building new capabilities, supporting evidence-based patient programmes, and measuring health outcomes, companies can address rising disease burdens and capture emerging opportunities. This shift must prioritize ethics, scientific integrity, patient welfare, and data protection.